Encapsulation, Release, and Cytotoxicity of Doxorubicin Loaded in Liposomes, Micelles, and Metal-Organic Frameworks: A Review
Doxorubicin (DOX) is one of the most widely used anthracycline anticancer drugs due to its high efficacy and evident antitumoral activity on several cancer types. However, its effective utilization is hindered by the adverse side effects associated with its administration, the detriment to the patie...
Main Authors: | Mihad Ibrahim, Waad H. Abuwatfa, Nahid S. Awad, Rana Sabouni, Ghaleb A. Husseini |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2022-01-01
|
Series: | Pharmaceutics |
Subjects: | |
Online Access: | https://www.mdpi.com/1999-4923/14/2/254 |
Similar Items
-
Acoustically-Activated Liposomal Nanocarriers to Mitigate the Side Effects of Conventional Chemotherapy with a Focus on Emulsion-Liposomes
by: Mah Noor Zafar, et al.
Published: (2023-01-01) -
Liposome encapsulation of doxorubicin and celecoxib in combination inhibits progression of human skin cancer cells
by: Singh S
Published: (2018-03-01) -
Computational approach to the design of hyaluronic acid copolymer based doxorubicin micelles
by: Yujiao Sun, et al.
Published: (2016-02-01) -
Thermosensitive Polymers and Thermo-Responsive Liposomal Drug Delivery Systems
by: Waad H. Abuwatfa, et al.
Published: (2022-02-01) -
Liposome-Micelle-Hybrid (LMH) Carriers for Controlled Co-Delivery of 5-FU and Paclitaxel as Chemotherapeutics
by: Md. Musfizur Hassan, et al.
Published: (2023-07-01)